Author

Mi Deng

Peking UniversityORCID 0000-0003-4291-0144Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Beidi Chen· 1 shared Bin MaiD· 1 shared Binlong CheniD· 1 shared Bushu Zhou· 1 shared Buyao Li· 1 shared Demin ZhouiD· 1 shared Fangjie WaniD· 1 shared Hailong ZhaoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Beidi Chen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature MaterialsPeer-reviewedMar 3, 2026

In situ generated vaccine-like pyroptosome for personalized cancer immunotherapy

Binlong Chen, Fangjie Wan, Heming Xia…·Yiguang Wang

This paper develops a nanoadjuvant that induces localized pyroptosis to generate vaccine-like pyroptosomes, enhancing anti-tumor immunity while avoiding systemic toxicity.

13 citationstop 1%

experimental assaycancer & tumor microenvironment

𝕏 PostBluesky

BioengineeringCell Reports MedicinePeer-reviewedJul 1, 2025

Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in-vivo CAR-T therapy for inflamm-aging

Zihan Zhang, Bin Ma, Buyao Li…·Lei Miao

This study develops cardiolipin-mimic lipid nanoparticles for in vivo CAR-T therapy without antibody modification, treating liver fibrosis and rheumatoid arthritis via circular uPAR CAR mRNA.

58 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky